{
    "ucits": true,
    "type": "ETP",
    "leverage": true,
    "derivatives": true,
    "swaps": false,
    "inverse": true,
    "replication_method": "synthetic",
    "complex_factors": [
        "Leverage factor of 3x daily short exposure",
        "Use of futures contracts for short exposure",
        "Daily reset and compounding effects increasing complexity",
        "Synthetic replication via derivatives (futures)",
        "High risk rating (7/7)",
        "Potential counterparty and collateral risks implicit in futures",
        "Complex payoff profile (inverse leveraged exposure)",
        "Recommended holding period of 1 day indicating complexity"
    ],
    "classification": "complex",
    "supporting_data": "The WisdomTree Gilts 10Y 3x Daily Short is a UCITS-eligible Exchange Traded Product (ETP) that provides a leveraged short exposure (-3x) to the Long Gilt Rolling Future Index via futures contracts, which are derivatives. The product uses synthetic replication through futures, not physical holding of underlying securities. The leverage is significant (3 times daily), with daily reset and compounding effects that make the return profile complex and difficult for retail investors with basic knowledge to understand. The product carries a highest risk rating (7/7) and is intended for informed investors with specific knowledge or experience. The use of derivatives integral to the investment objective, the leverage, the inverse and daily reset features, and the synthetic replication method all contribute to complexity under MiFID II criteria. According to MiFID II Article 254 and Delegated Regulation EU 2017/565 Article 57, such features classify the product as complex, requiring an appropriateness assessment for retail investors. The productu2019s structure and risks are not straightforward, and the payoff depends on futures contracts with counterparty and collateral risks, which are difficult for average retail investors to understand. Therefore, despite being UCITS eligible, this ETF-like ETP is complex under MiFID II rules."
}